These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 29200697)
1. Uncommon Adverse Effects of Commonly Used Chemotherapeutic Agents in Medical Oncology Practice: A Series of Two Cases of Hand-Foot Syndrome. Dar W; Hussain M; Aziz SA; Mohammad G; Wani B; Latief M Indian J Med Paediatr Oncol; 2017; 38(3):380-382. PubMed ID: 29200697 [TBL] [Abstract][Full Text] [Related]
2. Do you know this syndrome? Hand-foot syndrome. Braghiroli CS; Ieiri R; Ocanha JP; Paschoalini RB; Miot HA An Bras Dermatol; 2017; 92(1):131-133. PubMed ID: 28225974 [TBL] [Abstract][Full Text] [Related]
3. Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome? Saif MW; Agarwal A; Hellinger J; Park DJ; Volkmann E Cureus; 2016 Jun; 8(6):e663. PubMed ID: 27493845 [TBL] [Abstract][Full Text] [Related]
4. Rare occurrence of hand-foot syndrome due to paclitaxel: A rare case report. Kataria PS; Kendre PP; Patel AA; Tahiliani N; Bhargav V; Parekh H Indian J Pharmacol; 2018; 50(5):284-286. PubMed ID: 30636833 [TBL] [Abstract][Full Text] [Related]
6. Hand-foot syndrome and its impact on daily activities in breast cancer patients receiving docetaxel-based chemotherapy. Hsu YH; Shen WC; Wang CH; Lin YF; Chen SC Eur J Oncol Nurs; 2019 Dec; 43():101670. PubMed ID: 31586645 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases]. Sasaoka S; Matsui T; Abe J; Umetsu R; Kato Y; Ueda N; Hane Y; Motooka Y; Hatahira H; Kinosada Y; Nakamura M Yakugaku Zasshi; 2016; 136(3):507-15. PubMed ID: 26935094 [TBL] [Abstract][Full Text] [Related]
8. [Adverse events in patients treated with capecitabine as adjuvant chemotherapy after surgery for colorectal cancer--countermeasures against hand-foot syndrome]. Suto T; Ishiyama K; Yabuki H; Mori N; Inoue K; Chiba M; Igawa A; Watanabe T; Fujimoto H; Suzuki Y; Sugawara M; Saito T; Kobayashi Y; Matsuda M; Ikeda E; Sato T; Iizawa H Gan To Kagaku Ryoho; 2010 Sep; 37(9):1729-33. PubMed ID: 20841936 [TBL] [Abstract][Full Text] [Related]
9. Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy. Heo YS; Chang HM; Kim TW; Ryu MH; Ahn JH; Kim SB; Lee JS; Kim WK; Cho HK; Kang YK J Clin Pharmacol; 2004 Oct; 44(10):1166-72. PubMed ID: 15342618 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome--recall following different chemotherapy agents. Hui YF; Giles FJ; Cortes JE Invest New Drugs; 2002 Feb; 20(1):49-53. PubMed ID: 12003194 [TBL] [Abstract][Full Text] [Related]
11. Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis. Liu Y; May BH; Zhang AL; Guo X; Lu C; Xue CC; Zhang H Integr Cancer Ther; 2019; 18():1534735418817833. PubMed ID: 30526124 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of hand-foot syndrome in the context of targeted therapies]. Cheron C Rev Infirm; 2019 Apr; 68(250):37-39. PubMed ID: 31147075 [TBL] [Abstract][Full Text] [Related]
14. [Hand-foot syndrome associated with uracil/tegafur and docetaxel in a patient with lung cancer]. Kanaji N; Bandoh S Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):474-8. PubMed ID: 17644943 [TBL] [Abstract][Full Text] [Related]
15. Hand-foot skin reaction is associated with the clinical outcome in patients with metastatic renal cell carcinoma treated with sorafenib. Nakano K; Komatsu K; Kubo T; Natsui S; Nukui A; Kurokawa S; Kobayashi M; Morita T Jpn J Clin Oncol; 2013 Oct; 43(10):1023-9. PubMed ID: 23956442 [TBL] [Abstract][Full Text] [Related]
16. A simple home-based self-monitoring tool for early detection of hand-foot syndrome in cancer patients. Mikoshiba N; Yamamoto-Mitani N; Ohki T; Asaoka Y; Yamaguchi H; Obi S; Sato K; Koike K; Miyashita M Jpn J Clin Oncol; 2016 Nov; 46(11):979-985. PubMed ID: 27511991 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. Miller KK; Gorcey L; McLellan BN J Am Acad Dermatol; 2014 Oct; 71(4):787-94. PubMed ID: 24795111 [TBL] [Abstract][Full Text] [Related]
18. Bleomycin lung toxicity: who are the patients with increased risk? Azambuja E; Fleck JF; Batista RG; Menna Barreto SS Pulm Pharmacol Ther; 2005; 18(5):363-6. PubMed ID: 15939315 [TBL] [Abstract][Full Text] [Related]
19. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S. Choy H; Shyr Y; Cmelak AJ; Mohr PJ; Johnson DH Cancer; 2000 Mar; 88(6):1336-46. PubMed ID: 10717614 [TBL] [Abstract][Full Text] [Related]
20. Managing toxicities associated with antiangiogenic biologic agents in combination with chemotherapy for metastatic colorectal cancer. Grenon NN Clin J Oncol Nurs; 2013 Aug; 17(4):425-33. PubMed ID: 23899982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]